This Biotech Stock Is Up 291% From Its IPO Price. It's On Pace for a Record Closing High.
CG OncologyCG Oncology(US:CGON) Barrons·2026-11-17 01:37

文章核心观点 - CG Oncology股价有望创下收盘历史新高,原因是其膀胱癌治疗药物的三期临床试验结果被称为“最佳情形” [1] 临床试验与股价表现 - 公司膀胱癌治疗药物在三期临床试验中取得“最佳情形”结果 [1] - 受该积极试验数据推动,公司股价有望创下收盘历史新高 [1]

This Biotech Stock Is Up 291% From Its IPO Price. It's On Pace for a Record Closing High. - Reportify